Ribavirin aerosol in hospitalized adults with respiratory distress and COVID‐19: An open‐label trial

• मुख्य लेखकों: Garyfallia Poulakou (लेखक), Maxime Barakat (लेखक), Robert J. Israel (लेखक), Marcelo R. Bacci (लेखक), Virazole Collaborator Group for COVID‐19 Respiratory Distress (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Wiley, 2023-01-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Abstract There is an unmet medical need for effective treatments for hospitalized patients with coronavirus disease 2019 (COVID‐19). Ribavirin is a broad‐spectrum antiviral with demonstrated in vitro activity against multiple viruses, including severe acute respiratory syndrome coronavirus 2 (SARS‐C...